lobbying_activities: 2772484

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2772484	b9f69c38-63e2-4c4a-8370-231610804ab0	Q1	THE NICKLES GROUP, LLC	293335	AMGEN	2022	first_quarter	GOV	H.R. 5376, The Build Better Back Act and issue regarding drug pricing. Issues regarding ESRD payments. H.R. 3517, Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021. Monitored the FDA user fee agreements.	HOUSE OF REPRESENTATIVES	50000		0	0	2022-04-12T17:46:48-04:00